Rapid pneumococcal evolution in response to clinical interventions

Science

Volumn 331, Issue 6016, 2011, Pages 430-434

  Croucher, Nicholas J ^a   Harris, Simon R ^a   Fraser, Christophe ^b   Quail, Michael A ^a   Burton, John ^a   Van Der Linden, Mark ^c   McGee, Lesley ^d   Von Gottberg, Anne ^e   Song, Jae Hoon ^f   Ko, Kwan Soo ^f   Pichon, Bruno ^g   Baker, Stephen ^h   Parry, Christopher M ^h   Lambertsen, Lotte M ⁱ   Shahinas, Dea ^j   Pillai, Dylan R ^j   Mitchell, Timothy J ^k   Dougan, Gordon ^a   Tomasz, Alexander ^l   Klugman, Keith P ^d,e,m,o   Parkhill, Julian ^a   Hanage, William P ^b,n   Bentley, Stephen D ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

ⁱ STATENS SERUM INSTITUT   (Denmark)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

^l ROCKEFELLER UNIVERSITY   (United States)

^m EMORY UNIVERSITY   (United States)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; POLYSACCHARIDE VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

BACTERIUM; EPIDEMIOLOGY; EVOLUTIONARY BIOLOGY; GENETIC ANALYSIS; PHENOTYPIC PLASTICITY; POLYMORPHISM; POLYSACCHARIDE; RECOMBINATION; VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DNA POLYMORPHISM; EVOLUTIONARY ADAPTATION; GENETIC RECOMBINATION; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PHYLOGENY; PHYLOGEOGRAPHY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 79251544864     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1198545     Document Type: Article

References (34)

1. K. L. O'Brien et al.; Hib and Pneumococcal Global Burden of Disease Study Team, Lancet 374, 893 (2009).
2. L. McGee et al., J. Clin. Microbiol. 39, 2565 (2001).
3. N. J. Croucher et al., J. Bacteriol. 191, 1480 (2009).
4. R. Muñoz et al., J. Infect. Dis. 164, 302 (1991).
5. C. M. Parry et al., Antimicrob. Agents Chemother. 46, 3512 (2002).
6. K. P. Klugman et al., Eur. J. Clin. Microbiol. Infect. Dis. 13, 171 (1994).
7. L. McGee, K. P. Klugman, D. Friedland, H. J. Lee, Microb. Drug Resist. 3, 253 (1997).
8. A. Tarasi, Y. Chong, K. Lee, A. Tomasz, Microb. Drug Resist. 3, 105 (1997).
9. A. Corso, E. P. Severina, V. F. Petruk, Y. R. Mauriz, A. Tomasz, Microb. Drug Resist. 4, 325 (1998).
10. R. Dagan, K. P. Klugman, Lancet Infect. Dis. 8, 785 (2008).
11. M. R. Moore et al., J. Infect. Dis. 197, 1016 (2008).
12. C. Muñoz-Almagro et al., Clin. Infect. Dis. 46, 174 (2008).
13. C. Ardanuy et al., J. Antimicrob. Chemother. 64, 507 (2009).
14. Materials and methods are available as supporting material on Science Online.
15. S. R. Harris et al., Science 327, 469 (2010).
16. E. J. Feil, J. M. Smith, M. C. Enright, B. G. Spratt, Genetics 154, 1439 (2000).
17. H. Ochman, S. Elwyn, N. A. Moran, Proc. Natl. Acad. Sci. U.S.A. 96, 12638 (1999).
18. T. L. McCool et al., Infect. Immun. 71, 5724 (2003).
19. L. Rose et al., J. Infect. Dis. 198, 375 (2008).
20. S. D. Bentley et al., PLoS Genet. 2, e31 (2006).
21. K. Trzciński, C. M. Thompson, M. Lipsitch, J. Bacteriol. 186, 3447 (2004).
22. K. E. Holt et al., Nat. Genet. 40, 987 (2008).
23. M. W. Pletz et al., Emerg. Infect. Dis. 12, 1462 (2006).
24. M. J. Ferrándiz et al.; Spanish Pneumococcal Infection Study Network, Antimicrob. Agents Chemother. 49, 2237 (2005).
25. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
26. J. H. Shaw, D. B. Clewell, J. Bacteriol. 164, 782 (1985).
27. M. Del Grosso, R. Camilli, F. Iannelli, G. Pozzi, A. Pantosti, Antimicrob. Agents Chemother. 50, 3361 (2006).
28. M. Del Grosso, J. G. Northwood, D. J. Farrell, A. Pantosti, Antimicrob. Agents Chemother. 51, 4184 (2007).
29. P. Romero et al., Plasmid 58, 51 (2007).
30. E. V. Pestova, D. A. Morrison, J. Bacteriol. 180, 2701 (1998).
31. A. Buu-Hoï, T. Horodniceanu, J. Bacteriol. 143, 313 (1980).
32. W. P. Hanage, C. Fraser, J. Tang, T. R. Connor, J. Corander, Science 324, 1454 (2009).
33. C. Colijn et al., J. R. Soc. Interface 7, 905 (2010).
34. We thank the participating surveillance networks, listed in table S1, and the core informatics, library-making, and sequencing teams at the Wellcome Trust Sanger Institute. Attending authors were grateful for the opportunity to discuss this project at the Permafrost conference. Sequence accession codes are given in tables S1 and S2. This work was funded by the Wellcome Trust.